BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31714012)

  • 1. A Novel Class of N-Sulfonyl and N-Sulfamoyl Noscapine Derivatives that Promote Mitotic Arrest in Cancer Cells.
    Yong C; Devine SM; Gao X; Yan A; Callaghan R; Capuano B; Scammells PJ
    ChemMedChem; 2019 Dec; 14(23):1968-1981. PubMed ID: 31714012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the structure and tubulin-targeted anticancer potential of N-(3-bromobenzyl) noscapine.
    Cheriyamundath S; Mahaddalkar T; Reddy Nagireddy PK; Sridhar B; Kantevari S; Lopus M
    Pharmacol Rep; 2019 Feb; 71(1):48-53. PubMed ID: 30465924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,3-Benzodioxole-Modified Noscapine Analogues: Synthesis, Antiproliferative Activity, and Tubulin-Bound Structure.
    Yong C; Devine SM; Abel AC; Tomlins SD; Muthiah D; Gao X; Callaghan R; Steinmetz MO; Prota AE; Capuano B; Scammells PJ
    ChemMedChem; 2021 Sep; 16(18):2882-2894. PubMed ID: 34159741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of novel N-alkyl amine analogues of noscapine, their chemical synthesis and cellular activity as potent anticancer agents.
    Meher RK; Pragyandipta P; Pedapati RK; Nagireddy PKR; Kantevari S; Nayek AK; Naik PK
    Chem Biol Drug Des; 2021 Sep; 98(3):445-465. PubMed ID: 34051055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synthesis and biological evaluation of multifunctionalised derivatives of noscapine as cytotoxic agents.
    Debono AJ; Mistry SJ; Xie J; Muthiah D; Phillips J; Ventura S; Callaghan R; Pouton CW; Capuano B; Scammells PJ
    ChemMedChem; 2014 Feb; 9(2):399-410. PubMed ID: 24339417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents.
    Santoshi S; Manchukonda NK; Suri C; Sharma M; Sridhar B; Joseph S; Lopus M; Kantevari S; Baitharu I; Naik PK
    J Comput Aided Mol Des; 2015 Mar; 29(3):249-70. PubMed ID: 25481458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel and improved antimitotic agents derived from noscapine.
    Anderson JT; Ting AE; Boozer S; Brunden KR; Crumrine C; Danzig J; Dent T; Faga L; Harrington JJ; Hodnick WF; Murphy SM; Pawlowski G; Perry R; Raber A; Rundlett SE; Stricker-Krongrad A; Wang J; Bennani YL
    J Med Chem; 2005 Nov; 48(23):7096-8. PubMed ID: 16279766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel biaryl type α-noscapine congeners.
    Manchukonda NK; Naik PK; Sridhar B; Kantevari S
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5752-5757. PubMed ID: 25453814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design of novel microtubule targeting anticancer drugs N-imidazopyridine noscapinoids: Chemical synthesis and experimental evaluation based on in vitro using breast cancer cells and in vivo using xenograft mice model.
    Pragyandipta P; Pedapati RK; Reddy PK; Nayek A; Meher RK; Guru SK; Kantevari S; Naik PK
    Chem Biol Interact; 2023 Sep; 382():110606. PubMed ID: 37330181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design, synthesis and biological evaluations of amino-noscapine: a high affinity tubulin-binding noscapinoid.
    Naik PK; Chatterji BP; Vangapandu SN; Aneja R; Chandra R; Kanteveri S; Joshi HC
    J Comput Aided Mol Des; 2011 May; 25(5):443-54. PubMed ID: 21544622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of noscapine analogues as microtubule-interfering agents.
    Dai HL; Zheng JB; Lin M; Zheng J; Zhou FS; Dong XC; Guo L; Liu JW; Wen R
    Yao Xue Xue Bao; 2012 Oct; 47(10):1347-57. PubMed ID: 23289148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubulin binding, protein-bound conformation in solution, and antimitotic cellular profiling of noscapine and its derivatives.
    Bennani YL; Gu W; Canales A; Díaz FJ; Eustace BK; Hoover RR; Jiménez-Barbero J; Nezami A; Wang T
    J Med Chem; 2012 Mar; 55(5):1920-5. PubMed ID: 22320354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of novel anti-microtubule agent (9-azido-noscapine) from quantitative structure activity relationship (QSAR) evaluation of noscapinoids.
    Santoshi S; Naik PK; Joshi HC
    J Biomol Screen; 2011 Oct; 16(9):1047-58. PubMed ID: 21972248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second generation benzofuranone ring substituted noscapine analogs: synthesis and biological evaluation.
    Mishra RC; Karna P; Gundala SR; Pannu V; Stanton RA; Gupta KK; Robinson MH; Lopus M; Wilson L; Henary M; Aneja R
    Biochem Pharmacol; 2011 Jul; 82(2):110-21. PubMed ID: 21501599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of S-phase arresting agents derived from noscapine.
    Anderson JT; Ting AE; Boozer S; Brunden KR; Danzig J; Dent T; Harrington JJ; Murphy SM; Perry R; Raber A; Rundlett SE; Wang J; Wang N; Bennani YL
    J Med Chem; 2005 Apr; 48(8):2756-8. PubMed ID: 15828811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death.
    Aneja R; Vangapandu SN; Lopus M; Viswesarappa VG; Dhiman N; Verma A; Chandra R; Panda D; Joshi HC
    Biochem Pharmacol; 2006 Aug; 72(4):415-26. PubMed ID: 16780803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design, chemical synthesis and cellular evaluation of novel 1,3-diynyl derivatives of noscapine as potent tubulin binding anticancer agents.
    Patel AK; Meher RK; Reddy PK; Pedapati RK; Pragyandipta P; Kantevari S; Naik MR; Naik PK
    J Mol Graph Model; 2021 Jul; 106():107933. PubMed ID: 33991960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 9-Arylimino noscapinoids as potent tubulin binding anticancer agent: chemical synthesis and cellular evaluation against breast tumour cells.
    Patel AK; Meher RK; Nagireddy PK; Pragyandipta P; Pedapati RK; Kantevari S; Naik PK
    SAR QSAR Environ Res; 2021 Apr; 32(4):269-291. PubMed ID: 33687299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of di-substituted noscapine analogs as potent and microtubule-targeted anticancer agents.
    Mishra RC; Gundala SR; Karna P; Lopus M; Gupta KK; Nagaraju M; Hamelberg D; Tandon V; Panda D; Reid MD; Aneja R
    Bioorg Med Chem Lett; 2015; 25(10):2133-40. PubMed ID: 25891106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming P-Glycoprotein-Mediated Drug Resistance with Noscapine Derivatives.
    Muthiah D; Henshaw GK; DeBono AJ; Capuano B; Scammells PJ; Callaghan R
    Drug Metab Dispos; 2019 Feb; 47(2):164-172. PubMed ID: 30478158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.